<DOC>
	<DOCNO>NCT01901419</DOCNO>
	<brief_summary>Hypothermic cardiopulmonary bypass result peripheral vasoconstriction heparin trap . Hypoperfusion ischemic-reperfusion injury associate systemic inflammatory response , insufficient delay neutralization heparin protamine may contribute blood loss rewarming stage . Nitroglycerin infusion , NO-related vasodilator , establish effective treatment unstable angina , myocardial infarction , congestive heart failure , perioperative hemodynamic management cardiac surgery . Therefore , hypothesize nitroglycerin infusion rewarming corrects systemic ischemic stress facilitates heparin neutralization cardiac surgery .</brief_summary>
	<brief_title>Nitroglycerin Infusion During Cardiac Surgery</brief_title>
	<detailed_description>A randomized clinical trial tertiary academic center patient cardiac surgery , receive either nitroglycerin infusion dose 0-0.1 mcg/kg/min , 1-5 mcg/kg/min rewarming cardiopulmonary bypass .</detailed_description>
	<mesh_term>Acidosis</mesh_term>
	<mesh_term>Acidosis , Lactic</mesh_term>
	<mesh_term>Nitroglycerin</mesh_term>
	<criteria>elective cardiac surgery heart failure , respiratory failure , asthma attack , uremia .</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>July 2013</verification_date>
	<keyword>nitroglycerin</keyword>
	<keyword>cardiopulmonary bypass</keyword>
	<keyword>cardiac surgery</keyword>
</DOC>